LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

LLY

1,075.18

+0.27%↑

JNJ

207.23

+0.6%↑

ABBV

227.72

+0.26%↑

UNH

325.11

-0.71%↓

AZN

91.53

+0.2%↑

Search

West Pharmaceutical Services Inc

Închisă

SectorSănătate

274.87 0.98

Rezumat

Modificarea prețului

24h

Curent

Minim

269.97

Maxim

278.02

Indicatori cheie

By Trading Economics

Venit

8.2M

140M

Vânzări

38M

804M

P/E

Medie Sector

40.335

76.798

EPS

1.96

Randament dividend

0.31

Marjă de profit

17.406

Angajați

10,600

EBITDA

19M

217M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+27.94% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.31%

2.37%

Data viitoare de dividende

4 feb. 2026

Următoarea dată ex-dividende

28 ian. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-209M

20B

Deschiderea anterioară

273.89

Închiderea anterioară

274.87

Sentimentul știrilor

By Acuity

50%

50%

166 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

West Pharmaceutical Services Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

22 dec. 2025, 23:54 UTC

Principalele dinamici ale pieței

Novo Nordisk ADRs Gain on FDA Approval of First GLP-1 in Pill Form

22 dec. 2025, 19:08 UTC

Achiziții, Fuziuni, Preluări

Correction to Alphabet to Buy Intersect Article

22 dec. 2025, 17:21 UTC

Achiziții, Fuziuni, Preluări

Alphabet to Buy Intersect for $4.75 Billion as AI-Investment Plans Grow -- Update

22 dec. 2025, 16:46 UTC

Achiziții, Fuziuni, Preluări

Alphabet to Buy Intersect for $4.75 Billion in Cash

22 dec. 2025, 23:50 UTC

Market Talk

Nikkei May Decline as Yen Rebounds -- Market Talk

22 dec. 2025, 23:42 UTC

Market Talk

Gold Hits Record High Amid Rising Geopolitical Risks -- Market Talk

22 dec. 2025, 22:31 UTC

Câștiguri

Zhejiang Sanhua Intelligent Controls: Higher Demand for Air-Conditioning Components Supported Results >002050.SZ

22 dec. 2025, 22:31 UTC

Câștiguri

Zhejiang Sanhua Intelligent Controls: Higher Demand for Refrigeration Supported Results >002050.SZ

22 dec. 2025, 22:30 UTC

Câștiguri

Zhejiang Sanhua Intelligent Controls Sees 2025 Net CNY3.87B, Up 25% on Year >002050.SZ

22 dec. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

22 dec. 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

22 dec. 2025, 21:37 UTC

Achiziții, Fuziuni, Preluări

Capricorn: Project Is Contiguous to Capricorn's Golden Range, Fields Find Tenure

22 dec. 2025, 21:36 UTC

Achiziții, Fuziuni, Preluări

Capricorn to Pay A$500,000 Cash, A$4M in New Shares

22 dec. 2025, 21:35 UTC

Achiziții, Fuziuni, Preluări

Capricorn to Acquire Prospective Package From Tempest Minerals

22 dec. 2025, 21:35 UTC

Achiziții, Fuziuni, Preluări

Capricorn Metals to Buy Yalgoo Project Tenement Package for A$4.5M

22 dec. 2025, 20:54 UTC

Achiziții, Fuziuni, Preluări

Middle West Partners Buys Paul Stuart From Mitsui & Co.

22 dec. 2025, 20:52 UTC

Achiziții, Fuziuni, Preluări

HCL Technologies: HCLSoftware to Acquire Jaspersoft From Cloud Software Group >532281.BY

22 dec. 2025, 20:09 UTC

Market Talk

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

22 dec. 2025, 19:56 UTC

Market Talk

Crude Gains as U.S. Increases Actions Against Venezuela -- Market Talk

22 dec. 2025, 19:49 UTC

Achiziții, Fuziuni, Preluări

A Topsy-Turvy Year for Oracle and the Ellisons Will Bleed into 2026 -- Barrons.com

22 dec. 2025, 19:23 UTC

Market Talk

Mexico's Inflation Seen Easing in Early December -- Market Talk

22 dec. 2025, 19:23 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22 dec. 2025, 19:02 UTC

Market Talk

Global Energy Roundup: Market Talk

22 dec. 2025, 19:02 UTC

Market Talk

Precious Metals Climb to New Heights -- Market Talk

22 dec. 2025, 18:45 UTC

Market Talk

Canadian Trade-Exposed Industries At Forefront of Job Weakness -- Market Talk

22 dec. 2025, 18:30 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Intersect Selling Portion of Assets as Part of Alphabet Deal -- Market Talk

22 dec. 2025, 18:23 UTC

Achiziții, Fuziuni, Preluări

What Yogi Berra Would Say About the Talks to Take Over Warner Bros. Discovery -- Barrons.com

22 dec. 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

22 dec. 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

22 dec. 2025, 17:06 UTC

Achiziții, Fuziuni, Preluări

Alphabet to Buy Intersect for $4.75B as AI-Investment Plans Grow -- Update

Comparație

Modificare preț

West Pharmaceutical Services Inc Așteptări

Obiectiv de preț

By TipRanks

27.94% sus

Prognoză pe 12 luni

Medie 348.7 USD  27.94%

Maxim 375 USD

Minim 285 USD

În baza a 12 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruWest Pharmaceutical Services Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

12 ratings

10

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

213.26 / 219.27Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

166 / 374 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat